Nasal high flow therapy introduction lowers reintubation risk in a Peruvian paediatric intensive care unit

Nielsen K.R.; Becerra M.R.; Mallma G.; Ellington L.E.; Onchiri F.; Roberts J.S.; Zunt J.; Tantaleán da Fieno J. · Acta Paediatrica, International Journal of Paediatrics (2020) · DOI: 10.1111/apa.15265

Resumen

Aim: We examined the impact of introducing high-flow nasal oxygen therapy (HFNT) on children under five with post-extubation respiratory failure in a paediatric intensive care unit (PICU) in Peru. Methods: This quasi-experimental study compared clinical outcomes before and after initial HFNT deployment in the PICU at Instituto Nacional de Salud del Niño in Lima in June 2016. We compared three groups: 29 received post-extubation HFNT and 17 received continuous positive airway pressure (CPAP) from 2016-17 and 12 historical controls received CPAP from 2012-16. The primary outcome was the need for mechanical ventilation. Adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) were calculated via survival analysis. Results: High-flow nasal oxygen therapy and CPAP did not alter the need for mechanical ventilation after extubation (aHR 0.47, 95% CI 0.15-1.48 and 0.96, 95% CI 0.35-2.62, respectively) but did reduce the risk of reintubation (aHR 0.18, 95% CI 0.06-0.57 and 0.14, 95% CI 0.03-0.72, respectively). PICU length of stay was 11, 18 and 37 days for CPAP, HFNT and historical CPAP and mortality was 12%, 7% and 27%, respectively. There was no effect on the duration of sedative infusions. Conclusion: High-flow nasal oxygen therapy provided effective support for some children, but larger studies in resource-constrained settings are needed.

Instituciones: Universidad Nacional Federico Villarreal